Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters

Database
Country/Region as subject
Language
Affiliation country
Publication year range
1.
PLoS One ; 10(1): e0116468, 2015.
Article in English | MEDLINE | ID: mdl-25635832

ABSTRACT

Human mesenchymal stem cells (hMSCs), the precursors of osteoblasts during osteogenesis, play a role in the balance of bone formation and resorption, but their functioning in uremia has not been well defined. To study the effects of the uremic milieu on osteogenic properties, we applied an in vitro assay culturing hMSCs in osteogenic medium supplemented with serum from healthy donors and from uremic patients on hemodialysis. Compared to control, serum from uremic patients induces, in hMSC cultures, a modification of several key regulators of bone remodeling, in particular a reduction of the ratio Receptor Activator of Nuclear factor Kappa B Receptor (RANKL) over osteoprotegerin, indicating an adaptive response of the system to favor osteogenesis over osteoclastosis. However, the levels of osteopontin, osteocalcin, and collagen type I, are increased in cell medium, while BMP-2, and alizarin red staining were decreased, pointing to a reduction of bone formation favoring resorption. Selected uremic toxins, such as p-cresylsulfate, p-cresylglucuronide, parathyroid hormone, indoxyl sulfate, asymmetric dimethylarginine, homocysteine, were able to mimic some of the effects of whole serum from uremic patients. Serum from cinacalcet-treated patients antagonizes these effects. Hydrogen sulfide (H2S) donors as well as hemodialysis treatment are able to induce beneficial effects. In conclusion, bone modifications in uremia are influenced by the capability of the uremic milieu to alter hMSC osteogenic differentiation. Cinacalcet, H2S donors and a hemodialysis session can ameliorate the hampered calcium deposition.


Subject(s)
Cellular Microenvironment , Mesenchymal Stem Cells/metabolism , Osteogenesis , Uremia/pathology , Adult , Bone Morphogenetic Protein 2/metabolism , Case-Control Studies , Cell Differentiation/drug effects , Cell Survival/drug effects , Cells, Cultured , Cellular Microenvironment/drug effects , Cinacalcet/pharmacology , Collagen Type I/metabolism , Culture Media , Female , Hemofiltration , Humans , Male , Mesenchymal Stem Cells/drug effects , Osteocalcin/metabolism , Osteogenesis/drug effects , Osteopontin/metabolism , Osteoprotegerin/metabolism , RANK Ligand/metabolism , Solubility , Uremia/blood
2.
J Med Case Rep ; 6: 417, 2012 Dec 11.
Article in English | MEDLINE | ID: mdl-23232027

ABSTRACT

INTRODUCTION: In the treatment of secondary hyperparathyroidism of chronic kidney disease, calcimimetics - allosteric modulators of the calcium-sensing receptor - inhibit glandular hyperplasia and significantly reduce circulating parathyroid hormone levels. They have a major impact on the management of secondary hyperparathyroidism. CASE PRESENTATION: We present the clinical case of a 41-year-old Caucasian man undergoing chronic hemodialysis, who had a parathyroidectomy to treat severe secondary hyperparathyroidism resistant to cinacalcet treatment. Preoperatively, 24 months after high-dose cinacalcet hydrochloride, we observed a persistently elevated intact parathyroid hormone serum level, and detected clear parathyroid gland hyperplasia regression on ultrasound. We performed a three-gland parathyroidectomy, which was assumed to be total, associated with a hemithyroidectomy. Our patient then entered a hypoparathyroid state. A histopathological examination showed that the removed parathyroid glands were of small size, with a total weight of 1g, associated with a multifocal small papillary thyroid cancer. CONCLUSION: In the management of secondary hyperparathyroidism, cinacalcet hydrochloride effectively reduces total parathyroid gland hyperplasia. However, a persisting elevated intact parathyroid hormone serum level may be observed, demonstrating that reduced parathyroid hyperplastic tissue may still be associated with severe secondary hyperparathyroidism. Even if calcimimetics are very effective in secondary hyperparathyroidism treatment, further studies are necessary for a better understanding of their actions.

3.
J Nephrol ; 21 Suppl 13: S32-50, 2008.
Article in English | MEDLINE | ID: mdl-18446731

ABSTRACT

CKD is utilized as a paradigm, a chronic disease which allows decades of life conquered with great effort through a machine, a life with many losses and many dependencies. We must understand the patient's needs, which are not related to availability of drugs and machines and hospitals. We cannot provide good medical care with the limited amount of national product devoted to health care. Society is much older than ever before. We need a new cadre of economists working on health care with vision and ability, keeping in mind that there are no resources and there are no expenses which can be cut in medical care nowadays. We have to switch from curative medicine towards prevention, by implementing clinical research, bearing in mind that in the Western world, democracy was granted through the correct allocation of resources. The search for happiness and good quality of life are old concepts born in the Mediterranean area over the centuries, starting with Hesiod and Homer, and sleep and dreams were being investigated centuries before Freud was born.


Subject(s)
Health Care Costs , Kidney Failure, Chronic/economics , Kidney Failure, Chronic/therapy , Philosophy, Medical , Quality of Life , Renal Dialysis/economics , Resource Allocation/economics , Survivors/psychology , Adaptation, Psychological , Attitude of Health Personnel , Biomedical Research/economics , Cost of Illness , Cost-Benefit Analysis , Dreams , Global Health , Health Care Costs/legislation & jurisprudence , Health Knowledge, Attitudes, Practice , Health Policy , Health Services Accessibility/economics , History, Ancient , Humans , Insurance, Health, Reimbursement , Italy , Kidney Failure, Chronic/prevention & control , Kidney Failure, Chronic/psychology , Models, Economic , Philosophy, Medical/history , Physician-Patient Relations , Renal Dialysis/psychology , Research Support as Topic , Resource Allocation/legislation & jurisprudence , Sleep , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL